Pubblicazioni ufficiali AbbVie Inc. London S.E.

Azioni

Tempo differito London S.E. Altri mercati azionari 09:06:19 07/05/2024			Variaz. 5gg	Var. 1 gen.
163,5 ^USD	+1,19%		+0,82%	+5,74%

30/04	Alvotech produrrà il biosimilare di Humira Adalimumab-ryvk per Quallent	MT
29/04	ABBVIE INC. : BMO Capital conferma il rating Buy	ZM

1st quarter results	26/04	CO
SEC Filing 8K	26/04	CO
SEC Filing 10K	20/02	CO
Annual results	02/02	CO
SEC Filing 8K	02/02	CO
SEC Filing 13G	25/01	CO
SEC Filing 8K	05/01	CO
SEC Filing 10Q-3	06/11	CO
3rd quarter results	27/10/23	CO
SEC Filing 8K	27/10/23	CO
SEC Filing 8K	12/10/23	CO
SEC Filing 8K	04/10/23	CO
SEC Filing 10Q-2	07/08/23	CO
1st-half-year results	27/07/23	CO
SEC Filing 8K	27/07/23	CO
SEC Filing 4K	12/05/23	CO
SEC Filing 8K	10/05/23	CO
SEC Filing 4K	09/05/23	CO
Shareholders meeting voting results	05/05/23	CO
SEC Filing 10Q-1	05/05/23	CO
SEC Filing 4K	05/05/23	CO
SEC Filing 4K	05/05/23	CO
SEC Filing 4K	05/05/23	CO
SEC Filing 4K	05/05/23	CO
SEC Filing 4K	05/05/23	CO